Purchases and Sales Made in Q4 2023 in Autolus Therapeutics PLC (AUTL)
This table provides information about the institutional ownership of Autolus Therapeutics PLC (AUTL) during Q4 2023. The information is specifically focused on institutions that hold shares of Autolus Therapeutics plc.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2024
Q4 2023
|
Lpl Financial LLC
Fort Mill, SC |
BUY
|
- |
219+ 0.54% |
$466 - $1.45K
|
40.5K
$121K
|
|
Feb 01, 2024
Q4 2023
|
Parkside Financial Bank & Trust
|
BUY
|
- |
200New |
$426 - $1.33K
|
200
$598
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 12, 2024
Q4 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-236- 2.29% |
$503 - $1.56K
|
10.1K
$30.1K
|
|
Feb 13, 2024
Q4 2023
|
Cetera Investment Advisers
Schaumburg, IL |
SELL
|
- |
-2.5K- 1.87% |
$5.33K - $16.6K
|
132K
$393K
|
|
Feb 13, 2024
Q4 2023
|
Rathbones Group PLC
Liverpool, X0 |
SELL
|
- |
-4K- 5.46% |
$8.52K - $26.5K
|
69.3K
$207K
|
|
Jan 29, 2024
Q4 2023
|
Wealth Effects LLC
|
SELL
|
- |
-4K- 8.51% |
$8.52K - $26.5K
|
43K
$129K
|
|
Feb 02, 2024
Q4 2023
|
Simplex Trading, LLC
|
SELL
|
- |
-4.34K- 24.05% |
$9.24K - $28.7K
|
13.7K
$40.9K
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-7.9K- 44.66% |
$16.8K - $52.4K
|
9.79K
$29.3K
|
|
Feb 13, 2024
Q4 2023
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-8.32K- 80.98% |
$17.7K - $55.1K
|
1.95K
$5.84K
|
|
May 21, 2024
Q4 2023
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-10.8K- 39.84% |
$22.9K - $71.4K
|
16.3K
$48.6K
|
|
Feb 09, 2024
Q4 2023
|
Mai Capital Management
|
SELL
|
- |
-17.6K- 4.76% |
$37.4K - $117K
|
352K
$1.05M
|
|
Feb 14, 2024
Q4 2023
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-47.2K- 8.05% |
$100K - $313K
|
539K
$1.61M
|
|
Oct 21, 2024
Q4 2023
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-58.1K- 27.38% |
$124K - $385K
|
154K
$461K
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-70.6K- 46.45% |
$150K - $468K
|
81.4K
$243K
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-114K- 41.68% |
$243K - $756K
|
160K
$477K
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-150K- 26.92% |
$320K - $995K
|
407K
$1.22M
|
|
Feb 13, 2024
Q4 2023
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-442K- 22.19% |
$942K - $2.93M
|
1.55M
$4.64M
|
|
Feb 14, 2024
Q4 2023
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-615K- 40.97% |
$1.31M - $4.07M
|
885K
$2.65M
|
|
Feb 14, 2024
Q4 2023
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-737K- 79.42% |
$1.57M - $4.89M
|
191K
$571K
|
|
Feb 14, 2024
Q4 2023
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-1.8M- 12.46% |
$3.82M - $11.9M
|
12.6M
$37.7M
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2.82M- 97.2% |
$6.01M - $18.7M
|
81.4K
$243K
|
|
Feb 13, 2024
Q4 2023
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-3.05M- 44.2% |
$6.5M - $20.2M
|
3.85M
$11.5M
|
|
Feb 14, 2024
Q4 2023
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-3.13M- 20.87% |
$6.67M - $20.8M
|
11.9M
$35.5M
|
|
Feb 14, 2024
Q4 2023
|
Tfg Asset Management Gp LTD
Grand Cayman, E9 |
SELL
|
- |
-4M- 33.33% |
$8.52M - $26.5M
|
8M
$23.9M
|